InvestorsHub Logo
Followers 0
Posts 613
Boards Moderated 0
Alias Born 01/27/2012

Re: None

Wednesday, 12/04/2013 12:59:05 PM

Wednesday, December 04, 2013 12:59:05 PM

Post# of 30442
Ecomans response to this question-
cartonet Member Level Sunday, 11/17/13 10:13:15 AM
Re: None



Post # of 11560






We, along with our scientific advisers, believe that shareholder interest will be best served by advancing Femprox in the U.S., only after this decision by the FDA, regarding this FSD product is known, which we expect to occur around year end.

Anyone know which product they are refering to?
eicoman Member Level Sunday, 11/17/13 11:31:48 AM
Re: cartonet post# 11209



Post # of 11560





http://investing.businessweek.com/research/stocks/private/snapshot.asp?privcapId=182739307
Flibanserin from Sprout Pharma
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News